Factory Supply Ledipasvir/Daclatasvir/Sofosbuvir/Entecavir CAS 1256388-51-8

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: CAS 1256388-51-8
• Certification: GMP, ISO 9001
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Purity: >98%
• Shipping: FedEx TNT UPS DHL
• Shelf Time: 2 Years
• Color: White
• Free Samples: Yes
• Stock: Yes
• Transport Package: Al-Foil Bag
• Specification: 1bags
• Trademark: HHD
• Origin: China
• Production Capacity: 1000bags

Product Description

 

WE ARE MANUFACTURER!
Factory supply, Higher quality, Lower Price!!

 

 

High quality 99% Anti HCV Sofosbuvir / Daclatasvir / Ledipasvir Powder
 

 

Ledipasvir is a direct acting antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). After completing Phase III clinical trials, on February 10, 2014 Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C.The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.
Ledipasvir is a potent inhibitor of HCV NS5A, a viral phosphoprotein that plays an important role in viral replication, assembly, and secretion, a hepatitis C virus protein.
 

Product Name:    Ledipasvir
Synonyms:    GS 5885;GS5885;GS-5885;Ledipasvir;GS-5885/Ledipasvir;gs-5885/gs5885;Ledipasvir / GS 5885;GS 588
CAS:    1256388-51-8
MF:    C49H54F2N8O6
MW:    889
EINECS:    1592732-453-0
Product Categories:    Inhibitors;API
Mol File:    1256388-51-8.mol


Ledipasvir is a potent NS5A inhibitor that is approved for use in combination with sofosbuvir, a nucleotide inhibitor of viral polymerase, for the treatment of chronic hepatitis C virus genotype 1 infection. This combination was discovered and developed at Gilead Sciences and is marketed as the fixed combination with brand name of Harvoni

Ledipasvir CAS 1256388-51-8 of Chemical Properties
Melting point     186-190oC
density     1.42±0.1 g/cm3(Predicted)
storage temp.     -20°C Freezer
solubility     DMSO (Slightly, Heated), Methan ol (Slightly)
form     Solid
pka    11.20±0.10(Predicted)
color     White to Pale Beige

1. Ledipasvir is most commonly used in combination with sofosbuvir for treatment in chronic hepatitis C genotype 1 patients. It inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion.

Packaging & Shipping

Our service

1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week  for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment: